
Mathijs Sanders
@mathijssanders
Researcher, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Visiting post-doc Sanger Institute, Cambridge, UK.
ID: 899624790079803392
https://scholar.google.com/citations?user=25WaFbIAAAAJ&hl=en#d=gs_hdr_drw 21-08-2017 13:30:38
451 Tweet
566 Takipçi
426 Takip Edilen


Extremely grateful for receiving the LSBR Fellowship! In this project we are investigating the drivers of acute myeloid leukemia with myelodysplastic related changes. Erasmus MC @erasmusmcblood #LSBR


Happy to report that we have received the Erasmus MC2 Research Innovation Grant! Sanne Massaar and the team will investigate the driver mechanisms behind disease progression in myeloid neoplasms. #MDS #AML #ErasmusMC #EMC



PhD candidate to study the bone marrow microenvironment in leukemia Mathijs Sanders Using cutting-edge technology, you will investigate the cell-intrinsic and cell-extrinsic drivers of AML. jobrxiv.org/job/erasmus-me… #single_cell_biology #spatial_multio... jobrxiv.org/job/erasmus-me…

Proud of the review by Roger Mulet-Lazaro on "Oncogenic Enhancers in Leukemia" in Blood Cancer Discovery in August issue. Great stuff for teaching! aacrjournals.org/bloodcancerdis… RogerMulet Blood Cancer Discovery



Join us! The Machado Lab at Cambridge University is looking for an enthusiastic RA to be a core member of the team and lead the lab's data generation efforts, seeking to understand how tumour and immune cells co-evolve and contribute to cancer progression. jobs.cam.ac.uk/job/47922/

🚨 Excited to share our latest paper in Cell identifying how under-replicated chromosomes in micronuclei become shattered by the Fanconi anemia pathway during mitosis. This work was led by UTSW Graduate School of Biomedical Sciences student Justin Engel. 🧵 (1/13): cell.com/cell/fulltext/…

New review by @sjfhermans, Niek van der Maas, Jurjen Versluis and others, detailing how real-world data can be of added value if collected and used appropriately!

Excited to share our latest study in Journal of Clinical Oncology on improving risk stratification for older patients (≥60 yrs) with Acute Myeloid Leukemia (AML)! We developed a novel prognostic model: AML60+. #Leukemia #AML link: ascopubs.org/doi/full/10.12… 🧵1/9



07 October 2024 at 16.00 CET Erasmus Hematology Virtual Lecture. We have: Kellie Machlus, Boston Children’s , with "Unraveling roles for megakaryocytes beyond platelet production through novel model systems" Spread the news! us06web.zoom.us/j/82722159417 Kellie Machlus





Delighted to share our latest on longitudinal methylation dynamics preceding cancer. Epigenetic signs of AML appear in blood DECADES before Dx. By brilliant Adriana Fonseca ✅Early cancer ✅Methylation drivers ✅Epimutation rates ✅CpG lineage tracing biorxiv.org/content/10.110…
